Table 4.
Grade III–IV complications of pc-RPLND according to Clavien-Dindo classification in relation to clinical factors
| Clinical factor evaluated | Eligible total (n) | Categories (eligible in category, n) |
Patients with complications (n), (%) | p valueb |
|---|---|---|---|---|
| Age | 143 | ≤ 30 years (n = 76) | 10 (13.2%) | 0.59 |
| > 30 years (n = 67) | 11 (16.4% | |||
| BMI | 131 | ≤ 29 kg/m2 (n = 103) | 12 (11.7%) | 0.18 |
| ≥ 30 kg/m2 (n = 28) | 6 (21.4%) | |||
| Laterality of primary | 137 | Right-sided (n = 68) | 6 (8.8%) | 0.06 |
| Left-sided (n = 69) | 14 (20.3%) | |||
| Duration of surgery | 67 | ≤ 269 min (n = 34) | (0%) | 0.001 |
| ≥ 270 min (n = 33) | 9 (27.3%) | |||
| Cisplatin dosage | 93 | < 500 mg (n = 18) | 2 (11.1%) | 0.83 |
| 500–700 mg (n = 45) | 4 (8.9%) | |||
| > 700mg (n = 30) | 4 (13.3%) | |||
| Number of resection fields a | 139 | ≤ 5 (n = 82) | 10 (12.2%) | 0.54 |
| > 5 (n = 57) | 9 (15.8%) | |||
| Teratoma in primary | 92 | Yes (n = 18) | 2 (11.1%) | 0.83 |
| No (n = 74) | 7 (9.5%) | |||
| Histology of resected specimen | 145 | Necrosis/fibrosis (n = 64) | 7 (10.9% | 0.02 |
| Teratoma (n = 65) | 8 (12.3%) | |||
| Viable cancer (n = 16) | 6 (37.5%) |
aResection fields according to Weissbach field classification [26]
bChi-squared test